WHO ICTRP trial
A clinical trial to test the safety of aripiprazole in children and adolescents…
EUCTR2012-003489-42-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-003489-42-HU |
|---|---|
| Public title | A clinical trial to test the safety of aripiprazole in children and adolescents with Tourette’s Disorder |
| Scientific title | An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents with Tourette’s Disorder |
| Primary sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United States;Finland;Spain;Italy;United Kingdom;Hungary;Mexico;Canada;Argentina;Poland;Belgium;Romania;Peru;Bulgaria;Netherlands;Germany;Sweden |
| Conditions | Tics associated with Tourette’s Disorder in children and adolescents MedDRA version: 14.1 Level: PT Classification code 10044126 Term: Tourette's disorder System Organ Class: 10010331 - Congenital, familial and genetic disorders… |
| Interventions | Trade Name: Abilify Product Name: Aripiprazole Pharmaceutical Form: Tablet INN or Proposed INN: ARIPIPRAZOLE CAS Number: 129722-12-9 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 5- Trade Name: Abilify… |
| Registration date | Apr 1, 2013 |
| Target size | 96 |
| Secondary IDs | 31-12-294 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: